CHU

First Patient Enrolled in the Streamlined Localization (STREAMLoc) Registry Study Using SCOUT® at Biopsy in Canada

Retrieved on: 
星期三, 七月 13, 2022

By implanting a tiny reflector, the size of a grain of rice, physicians may be able to precisely target affected tissue.

Key Points: 
  • By implanting a tiny reflector, the size of a grain of rice, physicians may be able to precisely target affected tissue.
  • The STREAMLoc registry study will add to the body of research supporting the use of the SCOUT system to improve efficiency in patient care between biopsy and surgery.
  • This is of high importance, particularly during the ongoing COVID-19 pandemic which has imposed substantial logistical challenges to healthcare delivery in Canada.
  • Study outcomes will be assessed from the initial placement of the SCOUT reflector during biopsy to its removal.

Yourgene Health Launches LightBench Detect for Fetal Fraction Enrichment

Retrieved on: 
星期一, 六月 20, 2022

The LightBench Detect helps NIPT providers to reduce no-call rates by optimising average fetal fraction.

Key Points: 
  • The LightBench Detect helps NIPT providers to reduce no-call rates by optimising average fetal fraction.
  • Use of the technology in NIPT offers scalable and precise DNA size selection and achieves >97% reproducibility, ensuring consistent enrichment of the fetal fraction.
  • The group worked with Yourgene to compare fetal fraction in 61 samples collected from singleton pregnancies in Vancouver over a two-month period.
  • Yourgene has now made this capability accessible to the market via the LightBench Detect.

Deenova´s France Remarkable and Continued Success Extends to French overseas departments: winning Mayotte, GHPSO and I.N.I. Awards

Retrieved on: 
星期一, 六月 20, 2022

Christophe Jaffuel , Deenova Chief Commercial Officer, added: A new milestone for Deenova is reached: expansion beyond the European continent, a great ongoing incentive for our sales teams.

Key Points: 
  • Christophe Jaffuel , Deenova Chief Commercial Officer, added: A new milestone for Deenova is reached: expansion beyond the European continent, a great ongoing incentive for our sales teams.
  • Centre Hospitalier de Mayotte , a public health establishment with 543 beds, is the only hospital in the overseas Department of Mayotte .
  • It is located in the northern part of the Mozambique Channel in the Indian Ocean off the coast of Southeastern Africa.
  • Institute Nationale des Invalides is placed under the supervision of the French Government Ministry of Defense and Veterans Affairs.

CIBC donates $1M to support the future of patient-centered care at the MUHC

Retrieved on: 
星期二, 六月 14, 2022

An innovative app improving the patient experience at the MUHC is expanding thanks to a $1 million gift from CIBC to the MUHC Foundation.

Key Points: 
  • An innovative app improving the patient experience at the MUHC is expanding thanks to a $1 million gift from CIBC to the MUHC Foundation.
  • It will also provide patients the reassurance that anomalies in their health will be noticed by their health care team and addressed quickly.
  • Patients will be able to share their anonymized data with scientists to enable studies that will ultimately improve patient care.
  • The MUHC Foundation is grateful to CIBC for its generous gift to support Opal.

Oncopole, FRQS cancer division, announces the winners of its "Priorité patient" 2022 Competition

Retrieved on: 
星期一, 六月 13, 2022

This competition provides financial support for research projects aimed at improving the care and services for people living with cancer in Quebec.

Key Points: 
  • This competition provides financial support for research projects aimed at improving the care and services for people living with cancer in Quebec.
  • This competition is carried out in collaboration with the Unit de soutien au systme de sant apprenant (SSA) Qubec and the Programme qubcois de cancrologie of the MSSS.
  • The context of the pandemic has highlighted the lack of emotional support for people affected by cancer.
  • Chemoradiotherapy treatments are known to produce significant side effects in people treated for head and neck cancer often leading to swallowing disorders or dysphagia.

Two Alithya projects are nominated for Québec OCTAS awards

Retrieved on: 
星期一, 五月 9, 2022

Each year, the general public and the jury of this prestigious contest held by the Rseau Action TI vote for projects that leverage digital and information technologies in Qubec.

Key Points: 
  • Each year, the general public and the jury of this prestigious contest held by the Rseau Action TI vote for projects that leverage digital and information technologies in Qubec.
  • National Bank's Fabrique aux automatisations is nominated for two OCTAS: the People's Favourite and the Process Transformation Large Company awards.
  • Alithya also developed a web application that let hospital staff answer volunteer requests and check their patient requests in real time.
  • The winners of the OCTAS awards will be announced on June 8, 2022, in Montral.

The FORMULA 1 CANADIAN GRAND PRIX Announces the Return of its Opening Gala : The Grand Evening

Retrieved on: 
星期五, 四月 29, 2022

In a sumptuous dcor at the heart of enticing performances, Le Grand Soir is without a doubt the most sought-after event of the summer.

Key Points: 
  • In a sumptuous dcor at the heart of enticing performances, Le Grand Soir is without a doubt the most sought-after event of the summer.
  • On June 16th, Montreal's Winsor Station will host Le Grand Soir presented by Bell.
  • ''Following a two-year absence that seemed never ending, I am overjoyed to see the festivities surrounding the Formula 1 Canadian Grand Prix return.
  • Le Grand Soir is the staple of summer in Montreal and will once again bring together the world of Formula 1 and the Montreal community'' Franois Dumontier, President and CEO of the Formula 1 Canadian Grand Prix.

IceCure Medical Presents ICE3 Breast Cancer Trial Interim Data, Hosts Cryoablation Symposium & Conducts Hands-On ProSense® Training Sessions at the European Conference on Interventional Oncology

Retrieved on: 
星期三, 四月 27, 2022

On April 25, Professor Franco Orsi, MD, PhD of the European Institute of Oncology in Milan, Italy moderated the IceCure Industry Symposium: Liquid Nitrogen Based Cryoablation for Optimal Tumor Destruction.

Key Points: 
  • On April 25, Professor Franco Orsi, MD, PhD of the European Institute of Oncology in Milan, Italy moderated the IceCure Industry Symposium: Liquid Nitrogen Based Cryoablation for Optimal Tumor Destruction.
  • Dr. Kenneth R. Tomkovich, Co-Primary Investigator of the ICE3 trial, presented promising interim data on cryoablation of small, low-risk breast cancers on April 26.
  • The interim results were originally published on April 29, 2021 and show almost 98% of patients who received ProSense System cryoablation treatment are recurrence free, with one-third of patients having reached 5 years post-treatment.
  • The IceCure team was joined by physicians well-experienced with the ProSense System to help guide participants during the sessions.

PSPDFKit Announces Record First Quarter 2022 Results

Retrieved on: 
星期三, 四月 13, 2022

VIENNA, and RALEIGH, N.C., April 13, 2022 /PRNewswire/ -- PSPDFKit, the leading document processing and manipulation platform for tomorrow's developers, today reported record bookings for Q1 2022. The bookings growth in the first quarter of 2022 was primarily driven by new customers, representing an organic year-over-year (YoY) growth of 75%.

Key Points: 
  • VIENNA, and RALEIGH, N.C., April 13, 2022 /PRNewswire/ --PSPDFKit, the leading document processing and manipulation platform for tomorrow's developers, today reported record bookings for Q1 2022.
  • The bookings growth in the first quarter of 2022 was primarily driven by new customers, representing an organic year-over-year (YoY) growth of 75%.
  • "We had a phenomenal quarter, thanks to our incredible team," said Jonathan Rhyne, Co-Founder and CEO of PSPDFKit.
  • The first quarter marked a period of record employee growth, with significant additions across all teams to support rapid customer growth.

Deenova Wins UNIHA Largest Ever Pharmacy Automation Public Tender Award in France

Retrieved on: 
星期二, 二月 15, 2022

Deenova announced today it exclusively won Lot # 2 (the largest and most comprehensive ever) UNIHA Tender for Pharmacy Automation for the next 4 years, beating all of its competitors in the market.

Key Points: 
  • Deenova announced today it exclusively won Lot # 2 (the largest and most comprehensive ever) UNIHA Tender for Pharmacy Automation for the next 4 years, beating all of its competitors in the market.
  • Loc Bessin , Managing Director of Deenova in France stated: It is indeed a testament to the teamwork at Deenova to transform the past non-exclusive UniHA relationship to an exclusive contract award that adds all of Deenova established and newly developed solutions to the UniHA portfolio for 1000+ hospitals in France.
  • UniHA , the Union of Hospitals for Purchasing, is a cooperative of French public hospital buyers created in 2005 by the hospital staff themselves (32 CHU and 20 CH).
  • As of 2022, 1.065 hospitals have joined the UniHA cooperative, with 115 GHT having conducted 5.6 billion in group purchases in 2021.